Pharma goes small for process improvement; Study links supply chain analytics with margin;

> Big spending by drugmakers on new facilities is giving way to a focus on manufacturing processes by, in part, using scalable technologies that allow for smaller, highly targeted projects. Story

> Drugmakers indicating stronger analytical capabilities (e.g., closer integration with customers on demand forecasting) also consistently demonstrate higher margins, in a recent study. Article

> The $150-million cleanup of manufacturing wastes and wastewater treatment residuals at a 78-acre Connecticut site formerly occupied by Pharmacia & Upjohn will restore wetlands and meadow habitat. Story

> Last week marked the launch of the Engineering and Physical Sciences Research Council Centre for pharma and chemical production, which aims to develop more effective and sustainable methods of manufacturing, being led by the University of Strathclyde in Glasgow. Article

> Johnson & Johnson has tapped pharmaceuticals division exec Denise Torres to lead the troubled McNeil Consumer division. Story

> Brand Index is an information service that will identify and track major providers of specific CMO services (e.g., product formulation, lyophilization, fill/finish) Story

> Jeremy Shultz, a 23-year-old convicted of abducting and robbing a pharmaceutical deliveryman in Charleston, WV, will spend at least 31 years in prison. Story

> A Brit will spend the next eight years behind bars for supplying more than 2 million doses of counterfeit drugs into the European supply chain. Story

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.